Login
Toggle navigation
Videos
Categories
Trending
Verisec's Freja Emerges as Top Choice for UK Public Sector Identity Management | Johan Henrikson , CEO & Co-founder at Verisec AB
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Johan Henrikson is the CEO & Co-founder at Verisec AB
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Vinco Ventures Co-CEO Ted Farnsworth Sets The Record Straight On ‘Hostile Takeover.' | Ross Miller, CEO, Vinco Ventures IncBBIG:NAQ
00:10:00
Spenser Skates, Amplitude CEO: Fortt Knox Earnings | Spenser Skates, CEO, Amplitude IncAMPL:NAQ
00:10:00
Scott Peterson on Leadership and Vision at Peterson Wealth Advisory | Scott M. Peterson, CEO, Peterson Wealth Advisory.
00:10:00
The Value of Hiring a Financial Advisor: Objectivity and Expertise | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
Steven Boland,Chief Executive Officer at Acrow Formwork and Construction Services
00:10:00
MetLife Investment Management Wins 2023 Clean Energy DC Award for Largest Rooftop Solar Array in DC
00:10:00
Quarterly Market Update: Navigating Bond Losses, Stock Volatility, and Federal Reserve Actions
00:10:00
Developing the Developed World|Peter Thiel,Managing Partner,Founders Fund
00:10:00
New Range Gold Corp. Acquires Argosy Gold Mine in Red Lake District, Ontario
00:10:00
Exploring the Depths: A Conversation with Mattias Johansson, CEO of Bravida | Mattias Johansson - CEO of Bravida Holding
00:10:00
CEO elaborates on global efforts to enhance early diagnosis of rare hereditary diseases and metabolomics approaches to address diverse patient populations | Dr. Arndt Rolfs, CEO, Centogene NV.
00:10:00
Desert Lion Energy: Fast-Tracking Lithium Production in Namibia